Medicare Enrolled

Dr. Lameck Symekah

Psychiatric/Mental Health Nurse Practitioner · Garland, TX
Low-engagement
3635 BROADWAY BLVD STE A, Garland, TX 75043
9727870060
In practice since 2021 (4 years)
NPI: 1669143525 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Symekah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Symekah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Symekah

Dr. Lameck Symekah is a psychiatric/mental health nurse practitioner in Garland, TX, with 4 years in practice.

Between the years covered by Open Payments, Dr. Symekah received a total of $6,198 from 30 pharmaceutical and/or device companies across 383 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatric/mental health nurse practitioner. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Symekah is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 4 years in practice$ $6,198 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,198
Total received (2021-2024)
Avg $1,550/year across 4 years
Top 6% in TX for psychiatric/mental health nurse practitioner
30
Companies
383
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,198 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,162
2023
$1,961
2022
$848
2021
$228

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,827
Lundbeck LLC
$504
Otsuka America Pharmaceutical, Inc.
$399
ITI, Inc.
$398
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$388
Neurocrine Biosciences, Inc.
$370
Teva Pharmaceuticals USA, Inc.
$363
Takeda Pharmaceuticals U.S.A., Inc.
$329
Vanda Pharmaceuticals Inc.
$237
Supernus Pharmaceuticals, Inc.
$230
Janssen Pharmaceuticals, Inc
$227
Alkermes, Inc.
$190
Almatica Pharma LLC
$141
Sunovion Pharmaceuticals Inc.
$95
OWP Pharmaceuticals, Inc.
$84
Ironshore Pharmaceuticals Inc.
$82
IDORSIA PHARMACEUTICALS US INC
$54
Bausch Health US, LLC
$43
E.R. Squibb & Sons, L.L.C.
$40
Corium, LLC
$28
Axsome Therapeutics, Inc.
$22
Tris Pharma Inc
$21
Merck Sharp & Dohme LLC
$19
JAZZ PHARMACEUTICALS INC.
$17
Merck Sharp & Dohme Corporation
$17
Eisai Inc.
$16
AbbVie Inc.
$15
Avanir Pharmaceuticals, Inc.
$14
Indivior Inc.
$14
Otsuka Pharmaceutical Development & Commercialization, Inc.
$14
Top 3 companies account for 44.0% of total payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · APLENZIN · ARISTADA · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COBENFY · Dayvigo · FANAPT · HETLIOZ · INGREZZA · INVEGA SUSTENNA · JORNAY PM · LATUDA · LOREEV XR · NUEDEXTA · Nuedexta · PERSERIS · QELBREE · QUVIVIQ · Qelbree · Quillichew ER · REXULTI · SUNOSI · Subvenite · TRINTELLIX · UZEDY · VRAYLAR
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for psychiatric/mental health nurse practitioner in TX.

Looking for a psychiatric/mental health nurse practitioner in Garland?
Compare psychiatric/mental health nurse practitioners in the Garland area by procedure volume, costs, and industry payment transparency.
Browse psychiatric/mental health nurse practitioners nearby

Geographic Context

Psychiatric/Mental Health Nurse Practitioners within 10 mi
530
Per 100K population
20.4
County median income
$74,149
Nearest hospital
BAYLOR SCOTT AND WHITE MEDICAL CENTER LAKE POINTE
3.3 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Symekah is a psychiatric/mental health nurse practitioner, and high industry engagement (low-engagement, top 6%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Symekah receive payments from pharmaceutical companies?
Yes. Dr. Symekah received a total of $6,198 from 30 companies across 383 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Symekah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Psychiatric/Mental Health Nurse Practitioners in Garland
Browse psychiatric/mental health nurse practitioners in Garland ranked by procedure volume and transparency data.
Highest volume
Top Psychiatric/Mental Health Nurse Practitioners in TX
Psychiatric/Mental Health Nurse Practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Psychiatric/Mental Health Nurse Practitioners in TX
Which TX psychiatric/mental health nurse practitioners receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
By company
Lundbeck LLC Payments to Doctors
See all physicians who received payments from Lundbeck LLC.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc..
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →